Scarica l'app Stockscreener
4.36
7.82%
-0.37
Dopo l'orario di chiusura:
4.01
-0.35
-8.03%
Precedente Chiudi:
$4.73
Aprire:
$4.12
Volume 24 ore:
54,670
Relative Volume:
0.31
Capitalizzazione di mercato:
$2.47M
Reddito:
$927.00K
Utile/perdita netta:
$-13.21M
Rapporto P/E:
-0.0207
EPS:
-210.8843
Flusso di cassa netto:
$-4.77M
1 W Prestazione:
-21.72%
1M Prestazione:
-18.77%
6M Prestazione:
-73.24%
1 anno Prestazione:
+40.42%
Intervallo 1D:
$4.12
$4.65
Intervallo di 1 settimana:
$3.6001
$5.91
Portata 52W:
$2.034
$80.10
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
4.36 | 2.47M | 927.00K | -13.21M | -4.77M | -210.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Scisparc Ltd Borsa (SPRC) Ultime notizie
SciSparc Subsidiary NeuroThera to Take Majority Stake in Quantum Trials Firm CliniQuantum - TipRanks
SciSparc’s Neurothera Labs announces publication of international patent - TipRanks
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - Bitget
SciSparc Ltd. Advances Collaboration with NeuroThera Labs Inc. and Clearmind Medicine Inc. for Novel Combination Therapy Targeting Obesity and MASLD. - Quiver Quantitative
SciSparc: NeuroThera Labs Announces Publication of - GlobeNewswire
SciSparc: $9.46 Million NeuroThera Deal To Acquire Majority Stake In Quantum Clinical Trials Firm CliniQuantum - Pulse 2.0
SciSparc, Subsidiary NeuroThera Labs Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails - marketscreener.com
SPRC Stock Price, Quote & Chart | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
NeuroThera to acquire 54% stake in quantum tech firm CliniQ - Investing.com South Africa
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails - Bitget
SciSparc says Neurothera Labs agrees to acquire majority stake in CliniQuantum - TipRanks
SciSparc Ltd. Subsidiary NeuroThera Labs Inc. Enters Share Purchase Agreement to Acquire Majority Stake in CliniQuantum Ltd. - Quiver Quantitative
Neurothera Labs Inc. Announces Definitive Agreement To Acquire Majority Stake In Cliniquantum Ltd. - TheNewswire
SciSparc Ltd. (SPRC) Schedule 13G/A amendment shows holder ≤5% - Stock Titan
Can SciSparc Ltd. stock resist market sell offsJuly 2025 Update & Accurate Trade Setup Notifications - Naître et grandir
Aug Reactions: What is the implied volatility of SciSparc LtdEarnings Summary Report & Fast Gain Stock Trading Tips - baoquankhu1.vn
Analyst Upgrade: Whats the beta of SciSparc Ltd stockPortfolio Update Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
SciSparc announces publication of Japanese patent application - MSN
SciSparc announces 1-for-9 reverse share split - Yahoo Finance
SciSparc to implement 1-for-9 reverse stock split Wednesday - Investing.com India
SPRC SEC FilingsScisparc 10-K, 10-Q, 8-K Forms - Stock Titan
SciSparc to implement 1-for-9 reverse stock split Wednesday By Investing.com - Investing.com Canada
SciSparc Falls 12% After Announcing 1-for-9 Reverse Share Split - Nasdaq
SciSparc to Enact 1-for-9 Reverse Share Split as Outstanding Shares Shrink - TipRanks
SciSparc Announces 1-for-9 Reverse Share Split - The Manila Times
SciSparc (NASDAQ: SPRC) to implement 1-for-9 reverse share split - Stock Titan
SciSparc Amends $10 Million Note Deal, Issues $2 Million Initial Convertible Note - TipRanks
SciSparc (SPRC) arranges up to $10M discounted convertible note deal - Stock Titan
Is SciSparc Ltd. stock safe for conservative investorsShare Buyback & Target Return Focused Stock Picks - mfd.ru
Why SciSparc Ltd. stock remains undervaluedJuly 2025 Rallies & Weekly Market Pulse Alerts - mfd.ru
SPRC PE Ratio & Valuation, Is SPRC Overvalued - Intellectia AI
SciSparc Sets Up $10 Million Convertible Note Facility With Warrants - The Globe and Mail
Can SciSparc Ltd. stock outperform in a bear market2025 Trading Recap & Momentum Based Trading Ideas - mfd.ru
Will SciSparc Ltd. stock benefit from infrastructure spendingProduct Launch & High Accuracy Investment Signals - mfd.ru
Will SciSparc Ltd. stock deliver strong dividend growth2025 Trading Volume Trends & Safe Swing Trade Setups - mfd.ru
SciSparc announces resale of 61.21M shares by selling shareholders; shares down - MSN
Should you avoid Star Equity Holdings Inc stock right nowMarket Movement Recap & Community Trade Idea Sharing - baoquankhu1.vn
SciSparc Shareholders Approve February Governance Agenda - TipRanks
Aug Sentiment: How correlated is SciSparc Ltd to the S P5002025 Earnings Impact & Real-Time Chart Pattern Alerts - baoquankhu1.vn
SciSparc subsidiary receives U.S. patent for antibiotic-enhancing cannabinoid technology - Investing.com Nigeria
SciSparc Subsidiary NeuroThera Wins U.S. Patent for Cannabinoid-Based Antimicrobial Resistance Platform - TipRanks
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome ... - Caledonian Record
SciSparc: NeuroThera Labs Granted U.S. Patent for - GlobeNewswire
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA - The Manila Times
Ideas Watch: What is the target price for SciSparc Ltd stockJuly 2025 Highlights & Target Return Focused Picks - baoquankhu1.vn
Aug Fed Impact: What is SciSparc Ltds TAM Total Addressable MarketMarket Trend Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Entry Recap: Is SciSparc Ltd backed by strong institutional buyingJuly 2025 Update & AI Enhanced Execution Alerts - baoquankhu1.vn
Market Trends: Is SciSparc Ltd part of any ETFWeekly Risk Summary & Verified Chart Pattern Trade Signals - baoquankhu1.vn
SciSparc acquires MUSE system IP portfolio to enter GERD device market - Investing.com Australia
SciSparc acquires MUSE system IP portfolio to enter GERD device market By Investing.com - Investing.com South Africa
Scisparc Ltd Azioni (SPRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):